Endnote export
%T Pricing and Patents of HIV/AIDS Drugs in Developing Countries %A Borrell, Joan-Ramon %J Applied Economics %N 4 %P 505-518 %V 39 %D 2007 %= 2011-04-01T03:12:00Z %~ http://www.peerproject.eu/ %> https://nbn-resolving.org/urn:nbn:de:0168-ssoar-239489 %X This paper provides empirical evidence on the impact of patents on drug prices across developing countries. It uses sales data on HIV/AIDS drugs in a sample of 34 low and middle-income countries between 1995 and mid-2000. The main findings are that patents do shift drug prices up, that drug prices are correlated to per capita income levels, and that drug firms follow a skimming strategy when pricing new HIV/AIDS drugs. That is, there is across country and intertemporal price discrimination in the global drug markets. %G en %9 journal article %W GESIS - http://www.gesis.org %~ SSOAR - http://www.ssoar.info